CLINICAL_TRIALS
trial_result
· 2015-03-10
Clinical Trial Update: Safety and Efficacy Study of Glufosfamide in Ovarian Cancer [Phase 2]
Summary
Phase 2 safety and efficacy study of Glufosfamide in ovarian cancer was terminated; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eleison Pharmaceuticals LLC. | Conditions: Ovarian Cancer | Phase 2 | Status: TERMINATED | Results posted: 2015-03-10